Company registration number 02140832 (England and Wales)
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
(A Company Limited by Guarantee)
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 7
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
31,176
12,154
Current assets
Debtors
4
20,184
34,124
Cash at bank and in hand
799,506
833,785
819,690
867,909
Creditors: amounts falling due within one year
5
(511,016)
(534,575)
Net current assets
308,674
333,334
Net assets
339,850
345,488
Reserves
Income and expenditure account
339,850
345,488
Total members' funds
339,850
345,488

The notes on pages 3 to 7 form part of these financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The directors of the company have elected not to include a copy of the income and expenditure account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 13 March 2026 and are signed on its behalf by:
Michael Thomas Seals
Director
Company registration number 02140832 (England and Wales)
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Income and expenditure
£
Balance at 1 January 2024 (as previously stated)
429,387
Prior year adjustment - correction of error
(54,334)
Balance at 1 January 2024 (as restated)
375,053
Year ended 31 December 2024:
Deficit and total comprehensive income
(29,565)
Balance at 31 December 2024
345,488
Year ended 31 December 2025:
Deficit and total comprehensive income
(5,638)
Balance at 31 December 2025
339,850

The notes on pages 3 to 7 form part of these financial statements.

ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Animal Medicines Training Regulatory Authority Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is Unit 1C Windmill Avenue, Woolpit Business Park, Woolpit, Bury St. Edmunds, Suffolk IP30 9UP.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Income and expenditure

Income and expenses are included in the financial statements as they become receivable or due.

Expenses include VAT where applicable as the company cannot reclaim it.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office Equipment
-20% on cost
Computers
-20% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to surplus or deficit.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Taxation

Tax is recognised in the statement of comprehensive income except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

1.7
Retirement benefits

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The asset of the plan are held separately from the Company in independently administered funds.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
13
13
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
3
Tangible fixed assets
Office Equipment
Computers
Total
£
£
£
Cost
At 1 January 2025
50,354
22,858
73,212
Additions
4,542
20,178
24,720
At 31 December 2025
54,896
43,036
97,932
Depreciation and impairment
At 1 January 2025
42,773
18,285
61,058
Depreciation charged in the year
2,948
2,750
5,698
At 31 December 2025
45,721
21,035
66,756
Carrying amount
At 31 December 2025
9,175
22,001
31,176
At 31 December 2024
7,581
4,573
12,154
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
9,097
17,609
Prepayments and accrued income
11,087
16,515
20,184
34,124
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
2,879
5,759
Corporation tax
4,873
6,163
Other taxation and social security
8,527
8,270
Other creditors
28,997
26,116
Accruals and deferred income
465,740
488,267
511,016
534,575
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
6
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
23,417
21,440

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

There was a balance of £nil due to the fund at year end (2024 - £nil).

7
Members' liability

The company is limited by guarantee, not having a share capital and consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up such amounts as may be required not exceeding £1.

8
Prior year adjustment

The opening balance of equity of the prior period has been restated as a result of a prior year adjustment.

The adjustment arises as a result of the correction of an accrual. The effect on opening reserves for the prior period was a decrease of £54,334. Any affected comparative amounts are shown as 'restated'.

9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its deficit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor:
Jonathan Moore ACCA
Statutory Auditor:
Whitings LLP
Date of audit report:
13 March 2026
ANIMAL MEDICINES TRAINING REGULATORY AUTHORITY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
10
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2025
2024
£
£
Within 1 year
11,786
11,786
Years 2-5
21,360
33,146
33,146
44,932
2025-12-31 2025-01-01 false false false 13 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Joanne Sylvia Jeffs Andrew McGuinness Cairns John Martin Blackwell Julie Claire Williams Bryan John Lovegrove Catherine McLaughlin Michael Thomas Seals Alison Jean Ward SR Dawson 02140832 2025-01-01 2025-12-31 02140832 2025-12-31 02140832 2024-12-31 02140832 core:FurnitureFittings 2025-12-31 02140832 core:ComputerEquipment 2025-12-31 02140832 core:FurnitureFittings 2024-12-31 02140832 core:ComputerEquipment 2024-12-31 02140832 core:CurrentFinancialInstruments 2025-12-31 02140832 core:CurrentFinancialInstruments 2024-12-31 02140832 core:RetainedEarningsAccumulatedLosses 2025-12-31 02140832 core:RetainedEarningsAccumulatedLosses 2024-12-31 02140832 bus:Director7 2025-01-01 2025-12-31 02140832 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 02140832 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 02140832 core:FurnitureFittings 2025-01-01 2025-12-31 02140832 core:ComputerEquipment 2025-01-01 2025-12-31 02140832 2024-01-01 2024-12-31 02140832 core:FurnitureFittings 2024-12-31 02140832 core:ComputerEquipment 2024-12-31 02140832 2024-12-31 02140832 core:WithinOneYear 2025-12-31 02140832 core:WithinOneYear 2024-12-31 02140832 core:BetweenTwoFiveYears 2025-12-31 02140832 core:BetweenTwoFiveYears 2024-12-31 02140832 bus:CompanyLimitedByGuarantee 2025-01-01 2025-12-31 02140832 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 02140832 bus:FRS102 2025-01-01 2025-12-31 02140832 bus:Audited 2025-01-01 2025-12-31 02140832 bus:Director1 2025-01-01 2025-12-31 02140832 bus:Director2 2025-01-01 2025-12-31 02140832 bus:Director3 2025-01-01 2025-12-31 02140832 bus:Director4 2025-01-01 2025-12-31 02140832 bus:Director5 2025-01-01 2025-12-31 02140832 bus:Director6 2025-01-01 2025-12-31 02140832 bus:Director8 2025-01-01 2025-12-31 02140832 bus:CompanySecretary1 2025-01-01 2025-12-31 02140832 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP